Practical approaches to omnichannel strategies for Medical Affairs

The term "omnichannel" gets borrowed heavily from commercial and marketing contexts. Do you think it means something fundamentally different when it's applied to Medical Affairs — and if so, what gets lost in translation?

Omnichannel works the same way in Medical Affairs as it does in commercial. You design a plan to get the right scientific content to the right stakeholders through the channels that matter most. The difference is in the objectives and KPIs you track, not in the underlying process.

Medical Affairs teams often sit at the intersection of science, compliance, and commercial pressure. How does that complexity affect the ability to build and execute a coherent omnichannel strategy?

Every team operates under competing pressures, but Medical Affairs feels it in the data more than anywhere else. The information you can use is often limited or structured differently than on the commercial side. That doesn’t make omnichannel impossible; it just forces you to look at planning and evidence through a different lens.

There's been a lot of conversation in the field about HCP segmentation. But what does a segment actually need to look like for an MSL to find it genuinely useful in a real conversation or planning session?

Segments have to be visibly different in ways that matter in the field. If an MSL can’t quickly tell which group a specific HCP belongs to, the segmentation isn’t practical. Clear distinctions grounded in data, channel preferences, and engagement patterns are what make segments usable in real conversations.

You work at the intersection of science communication and strategy. In your view, is the biggest gap in Medical Affairs omnichannel a technology problem, a data problem, or something else entirely?

The main hurdle isn’t tools or data; it’s clarity. Teams struggle more with defining what their omnichannel plan is actually meant to achieve and how the pieces fit together than with any specific platform limitation. Once that shared understanding is in place, the technology and data usually follow.

Measuring impact in Medical Affairs has always been complicated because patient outcomes are several steps removed from an MSL conversation or a digital touchpoint. How should teams think about building a measurement framework that's scientifically credible and organizationally useful?

You rarely get a straight line from one interaction to a patient outcome, so the measurement framework has to focus on credible intermediate indicators. Track the behaviors and knowledge shifts you believe lead to better care, show how omni-channel activity moves those measures, and then connect those trends to outcomes over time.

AI is increasingly part of these conversations. Where do you see it changing the work of Medical Affairs — and where do you think the hype runs ahead of the reality?

AI is reshaping how Medical Affairs consumes data, understands HCP needs, and delivers scientific information, and it is quickly becoming a core channel rather than just another tool. There are still limits, but we haven’t hit a point where the hype has clearly outpaced the value; the more relevant question is which parts of the job it isn’t touching yet.

The webinar touched on the idea that Medical Affairs teams often already have 60–70% of the data they need — they just haven't integrated it. What does that integration work actually look like in practice, and why is it so hard to do?

Integration means turning scattered data sources into a shared, usable picture of HCP engagement, and that’s hard because pharma organizations are often intentionally siloed. Someone has to own the effort, bring Medical, field teams, IT, and analytics together, and drive agreement on who contributes what and how the data will be stitched into a common view.

Omnichannel maturity models often describe a journey from fragmented to integrated. But in a heavily regulated industry like life sciences, what does it actually take to move along that maturity curve — and what tends to stall organizations?

Progress toward integration depends on involving the right stakeholders early, especially regulatory and compliance. When those teams help shape the omnichannel approach from the start, it’s much easier to move from isolated tactics to a coherent, compliant program.

If you could give one piece of advice to a Medical Affairs leader who is genuinely committed to improving how their team communicates science to HCPs — but doesn't know where to start — what would it be?

Pick one manageable, high-value area and build a small omni-channel pilot around it. Use that experience to learn what resonates, refine your approach, and then scale rather than trying to solve everything at once.